Table 1.

Vaccines administered to study participants and reported adverse events for the pharmacovigilance pilot study at the Institut Pasteur du Cambodge from March to May 2012 (N=184).

Vaccinea	No adverse event	Mainly redness and/or pain at the injection site	Mainly fatigue and/or weakness	Mainly fever	Mainly runny or congested nose	No reply	Total
Hepatitis A	1	0	0	0	0	0	1
Hepatitis B	39	4	3	1	0	30	77
Haemophilus influenza	2	0	0	1	0	0	3
Japanese encephalitis	9	0	0	0	0	1	10
MMR	0	0	0	0	0	1	1
Meningitis	2	0	0	0	0	0	2
Chickenpox	1	0	0	0	0	0	1
Pneumococcus	2	0	0	0	0	2	4
Rubella	0	0	0	0	0	1	1
Tetanus	13	3	1	0	0	3	20
Tetanus & rabies	2	0	0	0	0	2	4
DTCP	2	1	1	0	1	0	5
Typhoid	2	0	0	0	0	0	2
HPV	10	3	0	1	2	4	20
Influenza	17	0	0	0	0	5	22
Influenza & Hib	2	0	0	0	0	0	2
Influenza & tetanus	1	0	0	0	0	0	1
Rabies	0	1	0	0	0	0	1
Yellow fever	4	0	0	0	0	2	6
Yellow fever & meningitis	0	0	0	0	0	1	1
Total	109	12	5	3	3	52	184

^a MMR: measles, mumps, rubella; DTCP: diphtheria, tetanus, pertussis, polio; HPV: human papillomavirus; Hib: Haemophilus influenzae serotype B.